{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:14:50Z","timestamp":1792646090166,"version":"4.5.0"},"reference-count":131,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation Research"],"published-print":{"date-parts":[[2016,4,29]]},"abstract":"<jats:p>The direct oral anticoagulants (DOACs) represent a major advance in oral anticoagulant therapy and have replaced the vitamin K antagonists as the preferred treatment for many indications. By simplifying long-term anticoagulant therapy and improving its safety, the DOACs have the potential to reduce the global burden of thrombosis. Postmarketing studies suggest that the favorable results achieved with DOACs in the randomized controlled trials can be readily translated into practice, but highlight the need for appropriate patient, drug and dose selection, and careful follow-up. Leveraging on their success to date, ongoing studies are assessing the utility of DOACs for the prevention of thrombosis in patients with embolic stroke of unknown source, heart failure, coronary artery disease, peripheral artery disease, antiphospholipid syndrome, and cancer. The purpose of this article is to (1) review the pharmacology of the DOACs, (2) describe the advantages of the DOACs over vitamin K antagonists, (3) summarize the experience with the DOACs in established indications, (4) highlight current challenges and limitations, (5) highlight potential new indications; and (6) identify future directions for anticoagulant therapy.<\/jats:p>","DOI":"10.1161\/circresaha.116.306925","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T20:13:20Z","timestamp":1461874400000},"page":"1409-1424","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":111,"title":["Evolving Treatments for Arterial and Venous Thrombosis"],"prefix":"10.1161","volume":"118","author":[{"given":"Noel C.","family":"Chan","sequence":"first","affiliation":[{"name":"From the Population Health Research Institute (N.C.C., J.W.E.) and Department of Medicine (J.W.E., J.I.W.), McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada (J.W.E., J.I.W.); and Department of Medicine, Monash University, Clayton, Victoria, Australia (N.C.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Eikelboom","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute (N.C.C., J.W.E.) and Department of Medicine (J.W.E., J.I.W.), McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada (J.W.E., J.I.W.); and Department of Medicine, Monash University, Clayton, Victoria, Australia (N.C.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute (N.C.C., J.W.E.) and Department of Medicine (J.W.E., J.I.W.), McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada (J.W.E., J.I.W.); and Department of Medicine, Monash University, Clayton, Victoria, Australia (N.C.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304488"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.264903"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.276741"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14841-6"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.6.690"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.6.736"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-03-0183"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01166.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02939.x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03064.x"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-590323"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.019083"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.025569"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.023143"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.046888"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.5414\/CP201812"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847050-00001"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04369.x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010370974"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12075"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029694"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.053769"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.180240"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.050260"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.054866"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/11318170-000000000-00000"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03753.x"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","unstructured":"Chang M Yu Z Shenker A Wang J Pursley J Byon W Boyd RA LaCreta F Frost CE. Effect of renal impairment on the pharmacokinetics pharmacodynamics and safety of apixaban [published online ahead of print September 11 2015]. J Clin Pharmacol. doi: 10.1002\/jcph.633.","DOI":"10.1002\/jcph.633"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-08-0566"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015688"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318289bcba"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.4021"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-06-0443"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13810"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.05.001"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502000"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510991"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1411800"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2007.09.002"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063479"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.03.017"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007432"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000040"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.08.001"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus305"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2015.06.005"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv309"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.07.013"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000535"},{"key":"e_1_3_4_57_2","article-title":"Antithrombotic treatment in relation to age in patients with newly diagnosed atrial fibrillation in North America (GLORIA-AF phase II).","volume":"65","author":"Halperin JL","year":"2015","unstructured":"Halperin JL, Huisman M, Diener H-C, Dubner S, Ma C, Rothman K, Healey J, Zint K, Elsaesser A, Paquette M, Teutsch C, Lip G. Antithrombotic treatment in relation to age in patients with newly diagnosed atrial fibrillation in North America (GLORIA-AF phase II). J Am Coll Cardiol. 2015;65(10_S). doi:10.1016\/S0735-1097(15)61518-2.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.09.008"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.12.022"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906598"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004450"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007903"},{"key":"e_1_3_4_63_2","doi-asserted-by":"crossref","unstructured":"The EINSTEIN\u2013PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287\u20131297.","DOI":"10.1056\/NEJMoa1113572"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302507"},{"key":"e_1_3_4_65_2","doi-asserted-by":"crossref","unstructured":"The Hokusai-VTE Investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013;369:1406\u20131415.","DOI":"10.1056\/NEJMoa1306638"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571232"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.026"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-015-0893-5"},{"key":"e_1_3_4_69_2","doi-asserted-by":"crossref","unstructured":"Lyman GH Bohlke K Khorana AA et al.. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014. J Clin Oncol. 2015;33:654\u2013656.","DOI":"10.1200\/JCO.2014.59.7351"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207541"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113697"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.07.022"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143252"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035422"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-02-0131"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2008.01.132"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02748.x"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61445-7"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-10-0679"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800374"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60880-6"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa076016"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60734-0"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810773"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62125-5"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1006885"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.09.011"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-015-0057-x"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3675"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111096"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110899"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.11.006"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-09-0756"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-03-0265"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105819"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112277"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-11-0918"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.8.1471"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.650614"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.549"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-04-0346"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-012-0857-9"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-02-0150"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.132.suppl_3.17392"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-665927"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14003"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002322"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12961"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-364141"},{"key":"e_1_3_4_111_2","volume-title":"ClinicalTrials.gov. NCT02128841: Comparison of antithrombotic treatments after aortic valve replacement (CATHAR)","unstructured":"ClinicalTrials.gov. NCT02128841: Comparison of antithrombotic treatments after aortic valve replacement (CATHAR). Rivaroxaban: a new antithrombotic treatment for patients with mechanical prosthetic aortic heart valve). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02128841?term=CATHAR&rank=1. Accessed April 1, 2016."},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015710"},{"key":"e_1_3_4_113_2","doi-asserted-by":"crossref","unstructured":"Camm AJ Amarenco P Haas S Hess S Kirchhof P Kuhls S van Eickels M Turpie AGG. XANTUS: A real-world prospective observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. Eur Heart J. 2015;pii:ehv466.","DOI":"10.1093\/eurheartj\/ehv466"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-06-0453"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-06-0497"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001798"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1857"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5398"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22373"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-563577"},{"key":"e_1_3_4_121_2","doi-asserted-by":"crossref","unstructured":"Larsen TB Gorst-Rasmussen A Rasmussen LH Skjoth F Rosenzweig M Lip GY. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation. Am J Med. 2014;127:650\u2013656.e655","DOI":"10.1016\/j.amjmed.2014.01.031"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.07.024"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-08-0666"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04877.x"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-07-0510"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suv037"},{"key":"e_1_3_4_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.04.007"},{"key":"e_1_3_4_128_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.012061"},{"key":"e_1_3_4_129_2","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0143"},{"key":"e_1_3_4_130_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12845"},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.2761"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405760"}],"container-title":["Circulation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCRESAHA.116.306925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:59:29Z","timestamp":1715572769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.116.306925"}},"subtitle":["Role of the Direct Oral Anticoagulants"],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":131,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,4,29]]}},"alternative-id":["10.1161\/CIRCRESAHA.116.306925"],"URL":"https:\/\/doi.org\/10.1161\/circresaha.116.306925","relation":{},"ISSN":["0009-7330","1524-4571"],"issn-type":[{"value":"0009-7330","type":"print"},{"value":"1524-4571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"assertion":[{"value":"2016-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}